Search
for
Sort by
Research 61–90 of 1000+
- Alopecia areata following COVID-19 vaccine: a systematic review
- COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection
- Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial
- Association between alopecia areata and COVID-19: A systematic review
- Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
- Characteristics of telogen effluvium in COVID-19 in western Iran (2020)
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- COVID-19 Severity and Androgen Receptor Polymorphism
- COVID-19: A catalyst for innovative hybrid teledermatology workflows to increase access and improve patient care at a large group practice
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends
- COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Androgenetic alopecia in COVID-19: Compared to what?
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
- COVID‐19, androgens, and androgenic alopecia
- COVID-19 lockdown and beyond: Home practice solutions for developing microsurgical skills.
- Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- Skin Diseases Associated With COVID-19: A Narrative Review